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Despite evidence for a strong genetic contribution to several major psychiatric disorders, individual candidate genes account for only a
small fraction of these disorders, leading to the suggestion that multigenetic pathways may be involved. Several known genetic risk
factors for psychiatric disease are related to the regulation of actin polymerization, which plays a key role in synaptic plasticity. To gain
insight into and test the possible pathogenetic role of this pathway, we designed a conditional knock-out of the Arp2/3 complex, a
conserved final output for actin signaling pathways that orchestrates de novo actin polymerization. Here we report that postnatal loss of
the Arp2/3 subunit ArpC3 in forebrain excitatory neurons leads to an asymmetric structural plasticity of dendritic spines, followed by a
progressive lossof spine synapses.Thisprogressionof synapticdeficits correspondswithanevolutionofdistinct cognitive, psychomotor,
and social disturbances as the mice age. Together, these results point to the dysfunction of actin signaling, specifically that which
converges to regulate Arp2/3, as an important cellular pathway that may contribute to the etiology of complex psychiatric disorders.
Introduction
Dendritic spines are the primary targets of excitatory synaptic
input. Their morphology is defined by an internal actin cytoskel-
eton, which forms a meshwork of filamentous actin (F-actin)
(Korobova and Svitkina, 2010). Actin remodeling is crucial for
the activity-dependent structural plasticity of spines and forms of
long-term potentiation (LTP) and depression (LTD) (Kim and
Lisman, 1999; Fukazawa et al., 2003; Zhou et al., 2004; Bosch and
Hayashi, 2012). The Arp2/3 complex may be a major driver of
spine actin remodeling, as it is specifically enriched within a sub-
membrane region (20–100 nm from the membrane) surround-
ing the spine head (Ra´cz and Weinberg, 2008). This complex is
composed of seven subunits, which initiates branched filament
polymerization to create actin meshworks such as that of the
spine (Mullins et al., 1997). Arp2/3 is activated by neuronal
WASP and WAVE1 proteins, downstream of Rho-family GT-
Pases such as Cdc42 and Rac, which are themselves stimulated
during LTP (Fortin et al., 2010; Murakoshi et al., 2011).
Abnormalities in dendritic spines are associated withmultiple
neuropsychiatric disorders, including intellectual disability (ID),
schizophrenia (SZ), and autism spectrum disorders (ASD)
(Rudelli et al., 1985; Comery et al., 1997; Glantz and Lewis, 2000;
Ramakers, 2002; Govek et al., 2004; Kolomeets et al., 2005; Barros
et al., 2009; Hayashi-Takagi et al., 2010; Hutsler and Zhang, 2010;
Ito et al., 2010; Carlson et al., 2011; Penzes et al., 2011; Durand et
al., 2012). Accumulating evidence suggests a link between actin
remodeling pathways and psychiatric disorders. For example, the
SZ susceptibility genes DISC1 and DTNBP1 regulate actin dy-
namics in dendritic spines via Kalirin7-Rac signaling and Abi1-
WAVE, respectively (Hayashi-Takagi et al., 2010; Ito et al., 2010).
Likewise, the ASD susceptibility genes SHANK2 and SHANK3
function as spine scaffolding proteins for actin-regulatory mole-
cules, including the Rac and Arp2/3 regulators PIX and cortac-
tin (Hering and Sheng, 2003; Park et al., 2003; Wendholt et al.,
2006). Pathogenicmutations of SHANK3 are also associated with
abnormal spine actin remodeling (Durand et al., 2012). Regula-
tors of Rho-family GTPases, including ArhGEF6, WRP/srGAP3,
and OPHN1 as well as Rho-family effectors such as PAK3 and
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LIMK1 have been linked to ID and SZ (Frangiskakis et al., 1996;
Allen et al., 1998; Endris et al., 2002; Addington and Rapoport,
2009; Piton et al., 2011;Wilson et al., 2011; Ramakers et al., 2012).
Together, these studies lead to the hypothesis that dysregulated
actin remodeling may be a basis for multiple neurodevelopmen-
tal and psychiatric disorders.
Here, we tested this hypothesis by conditional mutagenesis of
the Arp2/3 complex, to clarify the relationship between the de
novo actin polymerization pathway in excitatory neurons and
phenotypes relevant to psychiatric disorders. We demonstrate
that loss of the critical Arp2/3 subunit, ArpC3, from postnatal
excitatory neurons disrupts the balance of structural plasticity in
dendritic spines, and leads to a gradual loss of spines and progres-
sive development of multiple abnormal behaviors, resembling
the progressive trajectory of certain psychiatric disorders, includ-
ing SZ. These findings suggest theArp2/3 pathway is a convergent
endpoint for spine plasticity and maintenance, whose disruption
in mice can model neuropsychiatric disorders.
Materials andMethods
Animals. Conditional ArpC3 knock-out animals were produced by ho-
mologous recombination at the Duke BAC Recombineering Core and
the Duke Transgenic Core Facility (Durham, NC). Briefly, a targeting
construct was prepared by bacterial artificial chromosome recombineer-
ing, placing LoxP sites flanking exon 2 of ArpC3. Embryonic stem cells
selected for neomyocin resistance were screened for homologous recom-
bination by PCR across the long and short targeting arms, using primers
within and outside of the targeting cassette. For behavioral testing,
CaMKII-Cre positive (stock no. 005359; The Jackson Laboratory) male
and female mice from heterozygous breeding pairs were transferred to
the Duke University Medical School Mouse Behavioral and Neuroendo-
crine Analysis Core Facility. Behavioral testing was conducted with WT
and cKO littermates.
For the morphological studies, ArpC3 conditional knock-out mice
were crossed with the SlickV-YFP-ERT2mouse line (generously provided
by Dr. Guoping Feng, MIT, Cambridge, MA) and the Rosa26-lox-stop-
lox-tdTomato reporter line (generously provided byDr. FanWang, Duke
University, Durham, NC). ArpC3 conditional knock-out mice were also
crossed with theCamKll-Cre line for TEM studies. Littermatemale and
femalemice fromheterozygous pairings were used in all experiments. All
mice were housed in the Duke University’s Division of Laboratory Ani-
mal Resources facilities and all procedures were conducted with a proto-
col approved by the Duke University Institutional Animal Care and Use
Committee in accordance with National Institutes of Health guidelines.
Fluorescence recovery after photobleaching. P6 ArpC3f/f pups deeply
anesthetizedwith isofluranewere decapitated; the hippocampuswas rap-
idly dissected intomedium containing the following (inmM): HEPES 25,
NaHCO3 2, sucrose 248, glucose 10, KCl 4, MgCl2 5, CaCl2 1. Then, 350
m slices were cut with a tissue chopper (Ted Pella) and transferred to
the surface of membrane inserts (Millipore) placed in culture media
containing the following (in mM): L-glutamine 1, CaCl2 1, MgSO4 2,
D-glucose 12.9, NaHCO3 5.2, HEPES 30, insulin 0.001, ascorbic acid
0.53, 20% heat-inactivated horse serum, 80%HEPS-basedMEM8.4 g/L.
The pHwas adjusted to 7.35with 1NNaOHandosmolaritywas adjusted
to 320Osm. Slice-containing plates weremaintained in a 37°C incubator
with 5% CO2. Five days after incubation, cultures were transfected bi-
olistically with a gene gun. Tomake bullets, 40g ofGFP-actin and 30g
of Cre recombinase (pBeta-actin promoter) constructs were usedwith 12
mg of 1.6 m gold particles (Bio-Rad).
Five days after transfection, membrane inserts were transferred to 5
cm Petri dishes and filled with preincubated culture media. Baseline
fluorescent intensities of randomly selected spines were measured three
times, and then bleached with a 488 nm laser at 100% intensity for 5
iterations, using an upright LSM 780 with 20 water-immersion lens
(Zeiss) at a pixel dwell time of 124s. Recovery of the fluorescence signal
on individual spines wasmeasured and collected every second, using Zen
software (Zeiss). Background fluorescence was subtracted from that of
target spine. Collected data (200 time points) were then normalized to
the average intensity of the first 3 baseline trials. Control unbleached
adjacent spines weremonitored to ensure that bleachingwas restricted to
the spine under study. Time constants were calculated using SigmaPlot
10.0 software and curve fitting with a single exponential equation [y 
a*(1exp(b*x))].
Analysis of dendritic spines in vivo. Triple mutants (ArpC3f/f:SlickV-
YFP-ERT2:Rosa26-lox-stop-lox-tdTomato) were treated with tamoxifen
(5 mg; daily oral administration) for 5 d from P30. One week, 2 weeks, 4
weeks, and 8 weeks after the last tamoxifen treatment, brain sections (40
m) were prepared and immunostained (see Immunohistochemical
methods, below). Images of dendritic spines in secondary or tertiary
branches of pyramidal neurons in CA1 region of hippocampus were
taken on a LSM 710 confocal microscope (Zeiss). All images were ac-
quired by z-series (0.13 m intervals) using a 63 oil-immersion objec-
tive. The z-series were deconvolved by Huygens Essential deconvolution
software (SVI) and then 3-D reconstructed, measured, and classified by
Imaris software (Bitplane). The criteria for classifying the spines were as
follows: Stubby, length (spine) 0.8m;Mushroom, length(spine) 3
m and max_width (head)mean_width (neck)*2; Long thin, mean-
_width (head)mean_width (neck); Filopodia: true.
Glutamate uncaging.Glutamate uncaging was performed as described
previously (Murakoshi et al., 2011). Slice preparation and biolistic trans-
fection were performed as described for the FRAP experiments. A Ti:
Sapphire laser was tuned to 720 nm to uncage the caged glutamate in
artificial CSF (ACSF) that contained (mM): NaCl 130.0, KCl 2.5,
NaHCO3 2,0,NaH2PO4 1.25, glucose 25.0, CaCl2 4.0, tetrodotoxin 0.001,
andMNI-caged L-glutamate 2.0 at 25–27°C. Structural LTP was induced
by 4–7 ms, 5–8 mW uncaging pulses applied at 0.5 Hz for 30 pulses.
Spines of neurons expressing mCherry and EGFP were imaged with a
1030 nm ytterbium-doped laser. Volume change wasmonitored bymea-
suring the change in the intensity of EGFP or mCherry fluorescence.
Golgi-Cox staining. Golgi-Cox staining procedures were performed as
described previously (Deng et al., 2010). Mice were deeply anesthetized
with isoflurane and then transcardially perfused with 4% PFA. Brains
were removed and treated with solutions A and B from the FD Rapid
GolgiStain Kit for 2 weeks, and then treated with solution C for 7 d.
Sections (100 m thick) were cut by cryostat and transferred to solution
C and incubated for 24 h at 4°C. After brief rinsing with distilled water,
floating sections were stained consecutively with solutionsD and E for 30
min and then transferred to a 0.05% gelatin solution. Sections were
mounted on glass slides, dehydrated through a graded series of ethanol
concentrations, and then mounted with Permount. Images were col-
lected by a MicroPublisher 5.0 MP color camera (QImaging) on a Zeiss
Axio Imager microscope under a 100 oil-immersion objective using
MetaMorph 7.6.5 software. For quantification, spine density from seg-
ments of secondary or tertiary branches of CA1 pyramidal neurons in the
stratum radiatum of the hippocampus were measured.
Electron microscopy. Transmission electron microscopy was per-
formed as described previously (Ra´cz and Weinberg, 2008). Mice were
deeply anesthetized by isoflurane, then transcardially perfused with sa-
line, followed by a mixture of depolymerized paraformaldehyde (4%)
and glutaraldehyde (0.2–2%) in 0.1 M phosphate buffer, pH 7.4; 50 m
coronal sectionswere cutwith aVibratome. Sections for electronmicros-
copy were postfixed in 1% osmium tetroxide in 0.1 M phosphate buffer
for 40 min and stained en bloc with 1% uranyl acetate for 1 h. After
dehydration in an ascending ethanol series and propylene oxide, sections
were infiltrated with Epon/Spurr’s resin (EMS) and flat-mounted be-
tween sheets of ACLAR plastic (EMS) within glass slides. Sixty nanome-
ter sections were cut with a Reichert Ultramicrotome (Leica), mounted
on 300 mesh copper grids, they were contrasted with Ultrostain II lead
(Fisher Scientific) and examined in a JEOLT1100 electronmicroscope at
80 KV; images were collected with a 12 bit 1024 1024 CCD camera.
Electron micrographs of randomly selected fields were taken from the
middle of the stratum radiatum of CA1 hippocampus and layers 4–5 of
the cerebral cortex for further analysis. Three-dimensional reconstruc-
tions were performed on the electronmicrographs obtained from 50 nm
serial sections mounted on Formvar-coated single slot nickel grids of
ArpC3f/f and cKO ArpC3f/f:CaMKII-Cre mice. On electron micro-
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graphs, apical dendrites of pyramidal neurons were identified and serial
sections were aligned, and reconstructed in three dimensions using the
freely available RECONSTRUCT software (SynapseWeb, Kristen M.
Harris, PI, http://synapses.clm.utexas.edu/). Spine circularity was de-
fined as 4(area/perimeter 2), so a perfectly round profile would have a
value of 1.0, and a line would have a value of 0.
Chemical LTD. Slice preparation, biolistic transfection, and imaging
were performed as described for the FRAP experiments. Following trans-
fectionwithGFP (control) or withGFPwithCre (KO) for 5–7 d, baseline
fluorescent intensities of spines were captured three times (2 min inter-
val), and then the slices were treated with prewarmed culture media
containing 20 M NMDA for 3 min. After washing with normal culture
media, the Petri dish containing the membrane insert was filled again
with normal culture media and then spines were monitored every 2 min
for 32 min using an upright LSM 780 with 20 water-immersion lens
(Zeiss). The spine volume was measured by ImageJ software (NIH) with
an equation of (target area * target intensity) (baseline area * baseline
intensity). Collected data (18 time points) were then normalized to the
average spine volume of the first three baseline trials.
Subcellular fractionation. Subcellular fractionation was performed as
described previously (Kim et al., 2009). Briefly, mice were deeply anes-
thetized with isoflurane and hippocampi were rapidly removed, homog-
enized with 10 strokes using a Teflon-glass homogenizer in ice-cold lysis
buffer containing the following (in mM): sucrose 320, HEPES 4, pH 7.4,
EGTA1, and protease/phosphatase inhibitors. The homogenate was cen-
trifuged at 700  g for 10 min at 4°C. The supernatant (S1) was centri-
fuged again at 12,000 g for 15min to obtain the synaptosomal fraction
(P2). For separating synaptosomal cytosol (LS1) and synaptosomal
membrane (LP1), the pellet (P2) was hypo-osmotically lysed (5% lysis
buffer; 95% distilled water containing 5% CHAPS and protease/phos-
phatase inhibitors) for 30 min and centrifuged at 35,000 g for 20 min.
The pellet (LP1) was resuspended in lysis buffer containing 1% Triton
X-100 and sonicated. The protein concentration was determined with
the Bradford protein assay (Bio-Rad).
Western blotting. Ten micrograms of samples were electrophoresed
through 12% SDS-PAGE (Bio-Rad), transferred onto a nitrocellulose
membrane (Whatman), and blocked with 5% nonfat dry milk in TRIS-
buffered saline (TBS; pH 7.4) containing 0.05% Tween-20. For detec-
tion, the membranes were probed with primary antibodies for 24 h at
4°C. The following primary antibodies were used: mouse anti-GluN2B
monoclonal antibody (BD), mouse anti-GluN1 monoclonal antibody
(Synaptic Systems), rabbit anti-GluA1 polyclonal antibody (Millipore),
mouse anti-GluA2 monoclonal antibody (Zymed), rat anti-PSD-
95 monoclonal antibody (LifeSpan BioSciences), mouse anti-CamKll-
monoclonal antibody (Zymed), rabbit anti-p-CamKllT286 polyclonal an-
tibody (Millipore Bioscience Research Reagents), rabbit anti-p-Cam-
KllT305/306 polyclonal antibody (Novus), rabbit anti--actin polyclonal
antibody (Abcam), rabbit anti-ArpC2 polyclonal antibody (Millipore),
and mouse anti-ArpC3 monoclonal antibody (BD). After washing, the
membraneswere incubatedwith horseradish peroxidase-conjugated sec-
ondary antibodies (GE Healthcare Life Sciences) for 1 h, washed, and
then developed using the ECL system (Thermo Scientific). Membranes
were then exposed to autoradiography films (Genesee Scientific), and the
filmswere scannedwith anEpson 1670 at 600 dpi. The optical densities of
bands were quantified with ImageJ software (NIH).
Immunohistochemistry. Immunohistochemistry was performed as de-
scribed previously (Kim et al., 2009). Briefly, mice were deeply anesthe-
tized with isoflurane and then perfused transcardially with TBS, pH 7.4,
containing 25U/ml heparin, followed by 4%paraformaldehyde (PFA) in
TBS. Brains were removed, postfixed overnight at 4°C in the same fixa-
tive, and then cryo-protected with 30% sucrose in TBS. Brains were cut
into 40 m sagittal sections by cryostat (Leica CM 3000), and stored at
20°C until use. Sections were treated with blocking solution (TBS con-
taining 5% normal goat serum and 0.2% Triton X-100) for 2 h and
incubated overnight at 4°C with chicken anti-GFP polyclonal antibody
(Abcam) and rabbit anti-RFP polyclonal antibody (Rockland). After
washing three times with TBS containing 0.2% Triton X-100, sections
were incubated with IgG conjugated to Alexa Fluor 488 IgG or Alexa
Fluor 555 IgG (Invitrogen) for 1 h at room temperature. Sections were
counterstained with a 4,6-diamidino-2-phenylindole solution (DAPI;
Sigma-Aldrich). After washing four times, the sections were coverslipped
with FluorSave (CalBioChem) aqueous mounting medium.
Primary neuronal culture and immunocytochemistry. Primary neuronal
cultures from mouse hippocampus were prepared as described previ-
ously (Carlson et al., 2011). Briefly, P0 pups were rapidly decapitated and
hippocampal neurons were collected, pooled, and plated onto poly-l-
lysine-treated coverslips. Neurons were cultured in Neurobasal A me-
dium supplemented with 2% (v/v) B-27 supplement and 1% (v/v)
GlutaMAX (Invitrogen). Neuronal transfections were performed with
5.0 g of pCAG-Cre-GFP using Lipofectamine 2000 (Invitrogen) ac-
cording to the manufacturer’s instructions on DIV5 after plating. To
detect endogenous ArpC3 by immunocytochemistry, samples were fixed
at DIV8 in 4% PFA/4% sucrose in PBS for 15 min at 37°C. They were
permeabilized and blocked with 0.2% Triton X-100 and 5% normal goat
serum in TBS at room temperature for 20 min. Samples were then incu-
bated with a mouse anti-ArpC3 monoclonal antibody (BD) overnight at
4°C. After washing with TBST (TBS containing 0.2% Triton X-100),
samples were incubated with Alexa Fluor 555 IgG for 1 h at room tem-
perature. After washing four times, coverslips were mounted onto the
glass slides using FluorSave (CalBioChem) aqueous mounting medium
and imaged on a Zeiss LSM 710.
Open field test.Mice were placed into an open field (AccuScan Instru-
ments) and their activities were monitored over 1 h under 350 lux illu-
mination usingVersaMax software (AccuScan Instruments). Locomotor
activity (distance traveled), rearing (vertical beam-breaks), stereotypical
activities (repetitive beam-breaks 1 s), and anxiety level (duration in
center area of arena) were measured in 5 min time-bins.
Prepulse inhibition. Prepulse inhibition (PPI) of the acoustic startle
response was measured with SDI equipment. After 5 min of acclimation
to the apparatus,mice were given three different types of trials: trials with
the startle stimulus only (40 ms 120 dB); trials with the prepulse stimuli
(20 ms) that were 4, 8, or 12 dB above the white-noise background (64
dB) and followed 100 ms later with the startle stimulus; and trials with
background stimuli (null trials) to control for backgroundmovements of
the animals. Each test session began with 7 startle trials, followed by
blocks of 5 null, 15 prepulse, and 9 startle trials presented in a pseudo-
random order, and ending with 5 startle trials. The average intertrial
interval was 15 s, with a range of 12 to 30 s. The peak startle response for
each trial wasmeasured between 35 and 65ms after the onset of the startle
stimulus. PPI was calculated as%PPI [1 (prepulse trials/startle-only
trials)]*100. The magnitude of the startle response was calculated as the
mean response from all trials, excluding the initial block or 7 and final
block of 5 trails.
Social affiliation test. The test apparatus consisted of three-chambers
(54 26 24 cm) illuminated at 80–110 lux. This test was composed of
two phases: nonsocial exploration and social affiliation testing. In the
first phase, theArpC3f/f or cKOArpC3f/f:CaMKII-Cremousewas placed
into the center chamber and two small empty wire-mesh cages were
located in each of the adjoining chambers. Themicewere given full access
to all three chambers for 10 min. The mouse was removed to its home
cage and a C3H/HeJ mouse was placed into one of the wire-mesh cages
while the other remained empty. For the second phase of testing, the
ArpC3f/f or cKOArpC3f/f:CaMKII-Cremouse were returned to the cen-
ter chamber and given full access to the apparatus for 10 min. All behav-
iorswere videotaped across both test phases and analyzed by theTopScan
program (CleverSys). Contact with a nonsocial or social stimulus was
defined as the mouse approaching the wire-mesh cage and its nose being
within 4 cm of the cage.
Y-maze. Spontaneous alternation in a Y-maze was conducted under
indirect illumination (80–90 lux) in a 3-arm Y-maze. The mouse was
placed into the center arm of themaze and permitted free exploration for
6 min. All tests were recorded and scored subsequently by an observer
who was blind to the genotypes of the mouse. Entry into an arm was
defined as the mouse being 1 body length into that arm, with both
hind-paws past the entrance to that arm. An arm alternation was defined
as three successive entries into each of the different arms. Alternation,
calculated as the total number of alternations divided by the total number
of arm entries minus 2, was expressed as a percentage.
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Novel object recognition. This test was con-
ducted using methods described previously
(Carlson et al., 2011)withminormodifications
under 80–100 lux illumination. Before testing,
littermate mice were exposed for 10 min to the
arena (48 22 18 cm) for three consecutive
days without any objects. The test consisted of
four phases (10min each): training (day 1) and
assessments of short-term memory (STM)
(day1), long-termmemory (LTM) (day 2), and
remotememory (RM) (day 8). At training, two
identical objects (T1 and T2) were placed 10
cm away from opposite corners of the arena. A
mouse was placed into center of the arena and
given full access to the apparatus. After 20min,
the mouse was returned to the arena and ex-
posed to the now familiar (T1/2) and a novel
object (N1) as a test for STM. Twenty-four
hours later, the mouse was returned to the
same arena with the familiar object (T1/2) and
a second novel object (N2) as an assessment of
LTM. Finally, RM was evaluated with the fa-
miliar object (T1/2) and a third novel object
(N3). Behaviors were analyzed with Ethovision
XT 7.0 software (Noldus Information Tech-
nology) and analyzed by an observer blinded to
the genotype of the mice. Contact with a given
object was defined as the mouse approaching
the object nose first, with the nose being within
1 cm of the object. Duration of nose contacts
with each object was measured. Preference
scores were calculated as the [(duration of con-
tactwith the novel objectduration of contact
with the familiar object)/Total duration of
contacts with both objects].
Statistical analyses. All data are expressed as
means  SEM and all statistics were analyzed
using SPSS programs (SPSS 20). Independent
t-tests were used for analysis of differences
between two groups. When comparing more
than two groups, ANOVA and Tukey’s post
hoc tests were used. To monitor changes over
time, repeated-measures ANOVA were run
followed by Bonferroni corrected pairwise
comparisons. A p 0.05 was considered sta-
tistically significant.
Results
Actin turnover defect in dendritic
spines following ArpC3 deletion
To investigate a potential role for Arp2/3
in postnatal excitatory neurons in vivo, we
generated an ArpC3 conditional allele tar-
geting exon 2, circumventing the embry-
onic lethality associated with the germline
deletion of ArpC3 in mice (Yae et al.,
2006). Studies confirmed the loss of
ArpC3 within 72 h after Cre expression in
ArpC3f/fmouse embryonic fibroblasts and
hippocampal neurons (Fig. 1A,B).
ArpC3 protein was present in hip-
pocampal synaptosomes, however, this was depleted in vivo upon
Cre-mediated deletion of the floxed allele (Fig. 1C). Previous work
hasdemonstrated that spine actin is predominantly filamentous and
turns over rapidly (Star et al., 2002). To assess the impact of ArpC3
deletion on actin filament turnover within dendritic spines, a fluo-
rescence recovery after photobleaching (FRAP) assay with ex vivo
ArpC3f/f hippocampal slices was performed. Five days after expres-
sion of GFP-actin (control) or GFP-actin combined with Cre re-
combinase (KO), we performed FRAP on randomly selected spines
of CA1 pyramidal neurons (Fig. 1D).
After photobleaching, GFP-actin/Cre recombinase-expressing KO
spines showed retarded and decreased actin filament turnover,
Figure 1. Reduced spine actin dynamics upon loss of ArpC3. A, Mouse embryonic fibroblasts (MEFs) were cultured from e13.5
ArpC3f/f embryos and infected with either GFP or GFP-Cre adenovirus. Western blot analysis of lysates 48 and 72 h after infection
confirmed the specific loss of ArpC3 at 72 h after infection (bottom), but not the related ArpC2 (top). B, Primary hippocampal
neurons from ArpC3f/fmicewere cultured and transfectedwith GFP-Cre or GFP (soluble fill). Seventy-two hours after transfection,
neurons were immunostained for ArpC3 (red), which showed a punctate staining pattern within the cell body and neurites.
GFP-Cre positive neuron (boxed region and outline) was negative for ArpC3 immunoreactivity. C, Synaptosomes purified from
ArpC3f/f or ArpC3f/f:CaMKIIa-Cremice were immunoblotted for ArpC3 (top) or-actin as a loading control (bottom).D, Image of a
hippocampal slice containing GFP-actin transfected neurons (left). GFP-actin is highly enriched in dendritic spines (middle).
Schematic of photobleaching followed by recovery (right) illustrating that fluorescent recoverymainly depends on the turnover of
existingactin filaments and reincorporationof freely-mobile unbleachedGFP-actinmonomers.E, Representative imagemontages
of Cre (top) and Cre (bottom panel) spines before and after (blue arrow) photobleaching (indicated by yellow arrows,
unbleached spine is indicated by red arrowheads). F, Graph depicting average fluorescence recovery for Cre and Cre spines.G,
Average fraction of spines (last 30 s) that recover, binned by extent of recovery, from0 to60% recovery. Scale bars are indicated
in each micrograph.
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compared with GFP-actin-expressing
control spines (Fig. 1E), although no dif-
ferences in basal levels of GFP-actin were
noted in KO spines compared with WT
spines. Control spines (n  48) displayed
80% recovery of fluorescence within 100 s
afterphotobleaching (average timeconstant
29.7 s), whereas GFP-actin/Cre recombi-
nase-expressing spines (n 143) showed a
slowing of the recovery of fluorescence (av-
erage time constant 33.8 s) and a reduc-
tion of maximum fluorescence recovery
(50%), indicating that actin remodeling
is severely diminished by ArpC3 deletion
(Fig.1F).Whereas90%ofWTspines recov-
ered to at least 60% of the original fluores-
cence, only 36%ofKOspines recovered to a
similar extent; 16% of KO spines showed
20% recovery (Fig. 1G), indicating a dra-
matic effect on spine actin dynamics conse-
quent to the loss of ArpC3. These results
demonstrate a critical role for the Arp2/3
complex inmediating normal actin dynam-
ics in dendritic spines.
Gradual and profound loss of spine
synapses by postnatal ArpC3 deletion
We generated triple mutant ArpC3f/f:
SlickV-YFP-CreERT2:Rosa26-lox-stop-lox-
tdTomato-fluorescent protein mice to
enable in vivo labeling and visualization of
Cre-positive and -negative neurons after
tamoxifen treatment (Fig. 2A). This ap-
proach allowed the morphology of neu-
ronswith andwithout Cre induction to be
identified and compared within the same
tissue. Moreover, Cre-mediated loss of
Figure 2. Progressive loss of dendritic spines upon ArpC3 deletion. A, Schematic of triple mutant ArpC3f/f:SlickV-YFP:Rosa26-
lox-stop-lox-tdTomato mice. Induction of Cre activity with tamoxifen treatment induces deletion of ArpC3 and a lox-stop-lox
cassette to label neurons that have lostArpC3with tdTomato.Neurons lackingCre activity are only labeledwithYFP.B, Timeline for
experiments in the triple mutant mice showing the time-points for tamoxifen treatments and tissue collection. C, Representative
confocal images showing YFP (control, left) and YFP tdTomato (cKO, right) dendritic sections from the same tissue (middle; 8
weeks after tamoxifen). Regions of hippocampus are indicated; SO, stratum oriens; SR, stratum radiatum; DG, dentate gyrus. D,
Representative confocal imagesof dendritic sections fromstratumoriens, showingYFP (left), tdTomato (Cre-positive;middle), and
merge (right), indicating the selective loss of spines in Cre-expressing neuron (8 weeks after tamoxifen). E, Graph of spine density
1–8 weeks after tamoxifen treatment for control (YFP) and cKO (YFPtdTomato) neurons from CA1 stratum radiatum (SR; n
11–15 neurons for each genotype and time-point) and stratum oriens (SO; n 9–16 neurons for each genotype and time-point)
hippocampal regions. Two-way ANOVA for the numbers of spines revealed a significant main effect of time after Cre induction
(F(3,189)22.42,p0.001) andgroup (F(3,189)43.82,p0.001), anda significant timegroup interaction (F(9,189)7.99,
p 0.001). Bonferroni-corrected pairwise comparisons noted that there were no significant differences in spine number among
the four groups over the first 2 weeks after tamoxifen treatment. However, at 4 and 8 weeks the numbers of spines were significantly
reduced in both SR and SO hippocampus in Cre neurons comparedwith those in Cre control neurons (*p 0.001, from respective
controls). F, ArpC3f/f:CaMKIIa-Cremouse line. G, Representative sagittal section from CaMKII-Cre:Rosa26-lox-stop-lox-tdTomato
4
mouse at P26. tdTomato expression (red), a marker of Cre ac-
tivity, and DAPI nuclear stain (blue) are shown. H, Boxed re-
gions are expanded in G for the prefrontal cortex (PFC),
caudate–putamen (CPu), hippocampal CA1 and CA2 (Hip),
and cerebellum (CB) regions. OB, Olfactory bulb; Th, thalamus.
I, Representative immunoblots from Cre (Hip) and Cre
regions (CPu, CB) for ArpC3, Arp3, and-actin. Residual ArpC3
is likely to reflect Cre hippocampal glia and interneurons. J,
Visualization of spines from ArpC3f/f:CaMKIIa-Cre mice com-
pared withArpC3f/f controls by Golgi stain at P38 and P120. K,
Graph of spine density at P38 and P120. Independent t test
showed no difference of spine density between cKO mice and
littermate controls in P38 brains. However, P120 cKO mice
showed a significant decrease of spine density comparedwith
their littermate controls (t(1,4) 6.71, p 0.01), *p 0.01,
from controls at P120. L, Representative electronmicrographs
showing postsynaptic spines (orange) and presynaptic butons
(blue) in control and cKO CA1 hippocampus at P120.M, Graph
compares density of spine synapses in control and cKO sec-
tions from hippocampus [Cre (n  283 axospinous syn-
apses from 29 micrographs); Cre (n  196 axospinous
synapses from46micrographs), and cortex [Cre (n181axo-
spinous synapses from 31micrographs); Cre (n 113 axospi-
noussynapses from33micrographs).*p0.001, fromrespective
controls. Scale bars in eachmicrograph are indicated.
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ArpC3 could be induced postnatally and
any resulting changes in neuronal mor-
phology could be followed over time
(Fig. 2B).
Hippocampal sections (Fig. 2C,D)
were prepared at 1–8 weeks after tamox-
ifen treatment (P30–P35) and the spine
densities at each time point were mea-
sured. Surprisingly, there was no differ-
ence of spine density between ArpC3f/f:
Cre-positive (YFP/tdTomato double-
positive) KO neurons and ArpC3f/f:Cre-
negative (YFP single-positive) control
neurons for the first 2 weeks after tamox-
ifen treatment (Fig. 2E). However, by 4
weeks, a gradual decline in the spine den-
sity of KO neurons was evident, with a
43% reduction of spines in the stratum
radiatum at 8 weeks after tamoxifen (Fig.
2E). Thus, postnatal deletion ofArpC3 in-
duces a progressive loss of spines in vivo,
rather than their immediate collapse.
To confirm this progressive loss of
spines, we generated ArpC3f/f:CamKll-Cre
mice (Fig. 2F).CamKII-Cre expresses Cre
recombinase extensively within pyramidal
neurons of the CA1 hippocampal region
and cortical sub-regions such as the pre-
frontal cortex by P20 (Tsien et al., 1996)
(Fig. 2G,H). ArpC3 protein was specifically
lost in regions expressing Cre (Fig. 2I). At
P38 there were no differences between
ArpC3f/f and ArpC3f/f:CamKll-Cre spine
densities within the CA1 hippocampus
by Golgi stain analysis (Fig. 2 J,K). In
contrast, at P120 there was a 44% decrease
in spine density in the ArpC3f/f:CamKll-
Cre samples (Fig. 2 J,K), confirming the
progressive spine loss observed in the triple
mutant mice.
This postnatal spine loss is likely to re-
flect a corresponding loss of excitatory
spine synapses, a phenomenon thought to
contribute to several neuropsychiatric disorders (Feinberg, 1982;
Glantz and Lewis, 2000). To verify this inference, spine synaptic
contacts were further examined by transmission electronmicros-
copy in the ArpC3f/f:CamKll-Cre mutant mice (Fig. 2L). At 4
months of age, ArpC3f/f:CamKll-Cre mice experienced a 56%
loss of synapses onto spines in the stratum radiatum of the hip-
pocampus, and a 41% loss of spine synapses within the cerebral
cortex compared with controls (Fig. 2M), demonstrating that
ArpC3 deletion results in extensive but delayed loss of synapses
onto dendritic spines.
Asymmetric structural plasticity in spines upon
ArpC3 deletion
The gradual loss of spines was unexpected, since Arp2/3 is be-
lieved to be responsible for the primary structure of actin within
the spine (Korobova and Svitkina, 2010). We therefore asked
whether more subtle, yet physiologically important effects oc-
curredwithin the first 2 weeks ofArpC3 deletion, when our FRAP
analysis showed actin dynamics were affected, but before the on-
set of spine loss. Actin polymerization in spines is intimately
associated with LTP (Kim and Lisman, 1999; Fukazawa et al.,
2003) and is required for spine structural plasticity associated
with LTP (Okamoto et al., 2004). Rac, an upstream activator of
Arp2/3 present in spines, is rapidly turned on following LTP
induction (Fortin et al., 2010).We therefore determined whether
Arp2/3 is required for structural plasticity by uncaging glutamate
at single spines. ArpC3f/f hippocampal slices were biolistically
transfected with GFP (control) or GFP-Cre (knock-out), to-
gether with mCherry as a soluble fill (Fig. 3A). Six to eleven days
later, pulsed glutamate uncaging induced both transient and sus-
tained phases of structural plasticity in GFP-control stimulated
spines compared with adjacent unstimulated spines (Fig. 3B). In
contrast, GFP-Cre knock-out neurons completely lacked the sus-
tained phase of structural plasticity. This effect was rescued by the
expression of recombinant ArpC3 (Fig. 3C,D), demonstrating
that loss of ArpC3 prevents the maintenance of activity-induced
enlarged spines, before the onset of spine loss.
Regulation of actin filaments in response to activity is bidirec-
tional such that induction of LTD triggers spine shrinkage that is
dependent on actin depolymerization (Zhou et al., 2004; Bosch
Figure 3. Asymmetric structural plasticity of spines by ArpC3 deletion. A, Representative time course images before and after
glutamate uncaging showing control (top) and Cre-positive (bottom) spines. Time of uncaging is indicated above. Yellow arrow-
head indicates stimulated spine.B, Graphdepicting averaged time course of spine volume change in the sameexperiments as inA.
ANOVA with repeated measure for four groups (stimulated GFP-expressing spines, adjacent GFP-expressing spines, stimulated
GFP-Cre-expressing spines, and adjacent GFP-Cre-expressing spines) revealed a significant main effect of time-block (F(19,760)
9.31, p 0.001), group (F(3,40) 12.35, p 0.001), and significant time-blockgroup interaction effect (F(57,760) 4.45, p
0.001). Bonferroni-corrected pairwise comparisons noted that spine volume increases of KO neurons (stimulated GFP-Cre-
expressing spines) were significantly lower than those of control neurons (stimulated GFP-expressing spines) from the 10th
time-block (8 min after stimulation) (*p0.05). C, Representative images showing control (top) and ArpC3 rescued (bottom)
spines. Time of uncaging is indicated above. Yellow arrowhead indicates stimulated spine. D, Graph depicting averaged time
course of spine volume change in the same experiments as in C. No differences in stimulated control and rescued spines are seen.
E, Representative time course images before and after 20M NMDA treatment showing control (top) and Cre-positive (bottom)
spines. Green arrowheads indicate spines showingmarked volume loss. F, Graph depicting averaged time course of spine volume
change in the same experiments as in E. No differences between Cre control and Cre spines are seen.
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and Hayashi, 2012). We next addressed whether activity-
dependent spine shrinkage was intact in ArpC3 KO neurons.
ArpC3f/f hippocampal slices were transfected with GFP (control)
or GFP combined with Cre (knock-out) (Fig. 3E) to visualize
spines. Five to seven days later, slices were treated with 20 M
NMDA for 3 min to induce a chemical LTD (Lee et al., 1998).
Monitoring spine volume revealed that both control and Cre-
positive KO spines were rapidly reduced to 70% of original vol-
ume, and maintained the reduced volume for over 30 min (Fig.
3F), indicating normal activity-dependent spine shrinkage in
ArpC3-deficient neurons. Together, these data suggest the loss of
ArpC3 uncouples the bidirectional modulation of spine mor-
phology with plasticity. Thus, KO spines are likely to be biased
toward LTD-induced spine shrinkage due to an asymmetry of
activity-dependent morphological dynamics in KO spines.
Asymmetric spine structural plasticity is followed by an
accumulation of filopodia-like spines
The asymmetric structural plasticity of ArpC3 cKO neurons sug-
gested that a progressive accumulation of morphologically im-
mature spines may occur in vivo. To address this question, we
classified spines based on 3D-reconstructed images of den-
dritic sections at multiple times following
Cre induction using ArpC3f/f:SlickV-YFP-
CreERT2:Rosa26-lox-stop-lox-tdTomato-
fluorescent protein mice (Fig. 4A). At 1–2
weeks after Cre induction (when spine
loss was not observed), there were no sig-
nificant differences in morphology be-
tween control and cKO spines (Fig. 4B).
In contrast, at 4weeks after Cre induction,
the fraction of mushroom type spines de-
creased (67% of Cre control), while
filopodia-like spines increased (274% of
Cre control) in dendrites from cKOver-
sus control. These alterations of spine
morphologies were further exacerbated at
8 weeks after Cre induction. The fractions
of mushroom and filopodia-like spines
reached to 59% and 276% of their con-
trols respectively, in addition to a decrease
of stubby type spines (51% of Cre con-
trol) at this time point (Fig. 4B), suggest-
ing a delayed and gradual effect of ArpC3
deletion on spinemorphology. These pro-
gressive changes in spine morphology
were well matchedwith the progression of
spine loss shown in Figure 2E. Morpho-
logical differences between control and
knock-out spines were confirmed in EM
sections from adult ArpC3f/f:CamKll-
Cre mice (Fig. 4C). EM analysis also
revealed that spine heads in ArpC3f/f:
CamKll-Cre mice were more elongated
than those in ArpC3f/f control mice (Fig.
4D). Together, these data show that
Arp2/3 is required for activity-dependent
spine enlargement, and suggest this is im-
portant formaintaining an equilibrium of
normal spine morphology that may be
critical for the long-term maintenance of
normal spine density.
Reduced glutamate receptor expression and CaMKII
activation in synapses of ArpC3f/f:CaMKII-Cre mice
Spine morphology is correlated with synapse strength; large
mushroom-shaped spines contain larger postsynaptic densities
and more glutamate receptors than thin or filopodial spines
(Bourne and Harris, 2008). Since the actin cytoskeleton plays a
critical role in regulating PSD-95 dynamics within the spine
(Blanpied et al., 2008) and maintaining glutamate receptors
within synapses (Zhou et al., 2001), we hypothesized that Arp2/3
may influence PSD composition.We therefore analyzed the con-
tents of several PSD proteins in excitatory synapses of ArpC3f/f:
CamKll-Cre mice, using subcellular fractionation of hippocampi
from 4-month-old brains (Fig. 5A). Western blot analysis of
equal amounts of protein revealed significant reductions of
GluN2B (29 5%), GluN1 (39 8%), GluA1 (56 8%),
GluA2 (26  10%), and PSD-95 (33  8%) in the PSD-
containing LP1 fraction of mutant hippocampi compared with
controls (Fig. 5B), although the cytosolic (S2) level of GluA1 was
not changed. Loss of these PSD proteins correlated well with the
evidence of morphologically weaker spines. Functional weaken-
ing was further supported by estimating the level of activation of
CaMKII, an enzyme downstream of NMDA receptor-mediated
Figure 4. Altered spine morphology in ArpC3 cKO neurons. A, Reconstructed images from control (Cre) and cKO (Cre)
dendrites 1–8 weeks after tamoxifen treatment from ArpC3f/f:SlickV-YFP:Rosa26-lox-stop-lox-tdTomato neurons. Morphology of
individual spines is color-coded according to the key in B. B, Graph depicting the percentage of each morphological class of spine
over time after tamoxifen-mediated Cre induction. ANOVAwith repeatedmeasure revealed significant main effects of spine-type
(F(3,288) 178.7, p 0.001), spine-type genotype (F(3,288) 21.375, p 0.001), spine-type time (F(9,288) 10.76, p
0.001), and spine-typegenotype time (F(9,288)8.18,p0.001). However, an interaction betweengenotype timewas
not detected. Bonferroni-corrected pairwise comparisons noted that therewere no significant differences in spine classes between
genotypes over the first 2 weeks after tamoxifen treatment. However, at 4 weeks, mushroom-shaped spines in YFPtdTomato
double positive KO neuronswere selectively decreased, whereas, filopodia-like spineswere significantly increased comparedwith
YFP single positive control neurons (*p  0.001). At 8 weeks after tamoxifen treatment, stubby and mushroom spines in
YFPtdTomato double positive KO neurons were significantly decreased, whereas, filopodia-like spines were significantly in-
creased compared with YFP single positive control neurons (*p 0.001). n 13–15 neurons per genotype were used for each
time-point. C, Three-dimensional EM reconstructions of hippocampal dendrites fromArpC3f/f (control, left) andArpC3f/f:CaMKII-
Cre (cKO, right) mice showing representative differences in overall spine morphology and density. Postsynaptic density (PSD) is
indicated in red. D, Graph depicting the spine head circularity computed from electronmicrographs from control ArpC3f/f and cKO
ArpC3f/f:CaMKII-Cremice; 1.0 corresponds to a perfect circle. Hippocampus (n 283 for ArpC3f/f control, n 196 for ArpC3f/f:
CaMKII-Cre, *p 0.001, from control). Cerebral cortex (n 181 for ArpC3f/f control, n 113 for ArpC3f/f:CaMKII-Cre, *p
0.01, from control. Scale bars in each micrograph are indicated.
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calcium influx (Strack and Colbran, 1998). Phosphorylation of
CaMKIIThr286, indicative of CaMKII activation, was markedly
decreased in the LP1 fraction of ArpC3f/f:CamKll-Cre mice
(31  6%) (Fig. 5A,B). In contrast, no differences were ob-
served between genotypes in total CaMKII levels or in phosphor-
ylation of Thr305/306, a site correlated with CaMKII inactivation.
Together, these data demonstrate that loss of ArpC3 leads to the
accumulation of filopodial spines containing less PSD-95, fewer
glutamate receptors, and reduced downstream activation of
CaMKII.
Progressive onset of abnormal behaviors in ArpC3f/f:
CamKll-Cremice
We noticed that the adult ArpC3f/f:CamKll-Cre mice seemed
hyperactive in the home cage and interacted less often with cage-
mates than their control littermates. These observations led us to
conduct more detailed behavioral analyses of the mice. The ex-
periments reported above suggested two phases of progressive
cellular deficits—an early asymmetric structural plasticity of
spines, followed by a later phase of extensive synapse loss. Ac-
cordingly, we assessed the potential sequence of behavioral alter-
ations in young adolescents (P30–P40) and adults (P90–P120),
to determine whether the progressive cellular defects were asso-
ciated with a progressive onset of behavioral abnormalities.
Adolescent ArpC3f/f:CamKll-Cremice displayed levels of lo-
comotor (Fig. 6A), repetitive activities (Fig. 6C), and rearing be-
haviors (Fig. 6E) similar to their control littermates. In contrast,
adult (P90–P120) mutant mice showed a dramatic increase in
locomotor activity (Fig. 6B), aswell as increased repetitive behav-
iors (Fig. 6D) and rearing (Fig. 6F), demonstrating that their
abnormal hyperactivity and stereotypical behavior had a delayed
onset following the loss of ArpC3. However, both adolescent and
adult ArpC3f/f:CamKll-Cre mice spent similar time in the cen-
tral area of the arena comparedwith their littermate controls (Fig.
6G,H), suggesting normal anxiety levels in the mutant mice.
Figure 5. Reduced glutamate receptors and CamKll activation in PSD of ArpC3f/f:CaMKII-
Cremice. A, Representative immunoblots of subcellular fractions from ArpC3f/f (Cre; n 6)
and ArpC3f/f:CaMKII-Cre (Cre; n 6) adultmice at P120. Antibodies used in each panel are
indicated on the right. Bottom panel is a representative Coomassie-stained gel showing equiv-
alent total protein loading for each fraction. S2, Cytosol; P2, crude synaptosome; LS1, synapto-
somal cytosol; LP1, synaptosomal membrane.B, Graph of levels of each PSD component in LP1
fraction as a percentage of control, quantified from immunoblots in A. Independent t test
revealed significant reductions of GluN2B (t(1,10) 5.82, p 0.001), GluN1 (t(1,10) 5.57,
p 0.001), GluA1 (t(1,10) 7.83, p 0.001), GluA2 (t(1,10) 2.85, p 0.05), p-CamKll
T286
(t(1,10)  5.32, p  0.001), PSD-95 (t(1,10)  4.84, p  0.001) in adult (P120) ArpC3
f/f:
CaMKIIa-Cremice comparedwith those of littermate controls. However, total CamKll, p-Cam-
Kll T305/306, and -actin levels did not show any significant difference between cKO mice and
controls.
Figure 6. Analyses of open field behaviors in young and adult ArpC3f/f:CaMKII-Cre mice.
Analysis of behaviors of control ArpC3f/f and ArpC3f/f:CaMKII-Cremice at P30–P40 (A, C, E,G)
and at P90–P120 (B, D, F, H). A, B, Distance traveled in the open field test (OFT) over 1 h in
control andArpC3 cKOmice (adolescent n 15 control, n 13 cKO; adult n 37 control, n
43 cKO). Hyperactivity was increased only in adult cKOmice. ANOVAwith repeatedmeasure for
activity levels of four groups (genotypes of both adolescent and adult) revealed significantmain
effects of time-block (F(11,1144) 19.70, p 0.001) and group (F(3,104) 21.57, p 0.001),
but no time-block group interaction. Bonferroni corrected pairwise comparisons revealed
that activity levels of cKO mice were significantly higher than that of adolescent mice (both
controls and cKOs) and adult littermate controls throughout all time points (*p 0.001). C,D,
Stereotypical behavior as quantified by the number of repeated beam-breaks1 s in the open
field. ANOVA with repeated measure for four groups revealed significant main effect of group
(F(3,104) 16.44, p 0.001), but no time-block group interaction. Bonferroni-corrected
pairwise comparisons revealed no differences between adolescent control (ArpC3f/f) and cKO
(ArpC3f/f:CaMKIIaCre) mice (C). However, the level of stereotypic behaviors of cKO mice were
significantly higher than that of adolescent mice (both controls and cKOs) and adult littermate
controls throughout all timepoints (D) (*p0.001).E,F, Rearingbehaviors in the open field as
determined by the numbers of vertical beam-breaks for adolescentmice (left) and adult (right)
mice. ANOVA with repeated measure of four groups revealed significant main effect of group
(F(3,104)  21.23, p  0.001), and significant time-block  group interaction effect
(F(33,1144) 4.38, p 0.001). Bonferroni corrected pairwise comparisons revealed no differ-
ences between adolescent control and cKO mice (E). However, the levels of vertical activity of
cKO mice were significantly higher than that of adolescent mice (both controls and cKOs) and
adult littermate controls throughout all time points (F) (*p 0.05). G, H, Durations in center
area of open field were not significantly different between control and cKO mice both at ado-
lescent (G) and adult ages (H).
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PPI, a sensorimotor gating task, was analyzed next; this assay
is particularly intriguing, since reduced PPI is considered an en-
dophenotype for positive symptoms of schizophrenia in human
patients that may appear before other symptoms (Cadenhead et
al., 1993; Arguello and Gogos, 2006; Ziermans et al., 2011;
Ziermans et al., 2012). Both adolescent and adult ArpC3f/f:
CamKll-Cre mice showed significantly reduced PPI compared
with their littermate controls (Fig. 7A,B); basal startle responses
were similar between genotypes at both ages (data now shown).
These data suggest that precognitive processes are affected earlier
than activity in the ArpC3f/f:CamKll-Cremice.
Based on our initial observations, we suspected that social
interactionsmay be abnormal in theArpC3f/f:CamKll-Cremice,
leading us to conduct a social affiliation test (Fig. 7C,D). Adoles-
cent mutant and control mice strongly preferred the stimulus
mouse compared with a nonsocial object (Fig. 7C). In contrast,
adult mutants exhibited less preference for the social stimulus
mouse than their controls (Fig. 7D), although the total number of
contacts with social and nonsocial stimuli was not different be-
tween groups (data not shown), demonstrating that sociability
declines significantly in the ArpC3f/f:CamKll-Cre mice as they
reach adulthood.
Because the loss of ArpC3 reduced activity-dependent struc-
tural plasticity, we also analyzed cognitive behavior in themutant
mice. Cognitive symptoms of ArpC3f/f:CamKll-Cre mice were
assessed using Y-maze (working memory) and novel object rec-
ognition tests (episodic memory). Adolescent control and mu-
tant mice engaged in similar numbers of alternations in the
Y-maze, suggesting an intact working memory (Fig. 7E). In con-
trast, the percentage of alternations was slightly, but significantly
decreased in the adult ArpC3f/f:CamKll-Cre mice, indicating
their workingmemorywas impaired (Fig. 7F). In the novel object
recognition test (NOR), both adolescent and adult mutant mice
showed a significant disruption of episodic learning andmemory
(Fig. 7G,H). Compared with controls, ArpC3f/f:CamKll-Cre
mice were severely impaired in their ability to distinguish be-
tween the familiar and novel object at 20 min, 24 h, and 1 week
following the training, demonstrating thatArpC3f/f:CamKll-Cre
mice have early and pronounced deficits in short-term, long-
term, and remote memory capabilities. Together, these data in-
dicate that loss of ArpC3 in the ArpC3f/f:CamKll-Cre mice
results in an early and pervasive deficit in episodic memory, fol-
lowed by impaired working memory in adulthood.
Overall, our study demonstrates that conditional deletion of
ArpC3 in forebrain excitatory neurons leads to an early defect in
structural synaptic plasticity, followed later by a loss of synapses
onto dendritic spines. These synaptic abnormalities correspond
with early impairment of PPI and episodic memory, later fol-
lowed by hyperactivity, stereotypical behaviors, workingmemory
deficits, and social isolation (Fig. 8).
Discussion
Genetic interactions between multiple rare allelic variants can
predispose individuals to disorders such as ID, SZ, and ASD.
Figure 7. Analyses of PPI, sociability, workingmemory, and episodic memory in young and
adult ArpC3f/f:CaMKII-Cremice. A, B, Percentage PPI of acoustic startle responses at 4, 8, and
12dBprepulses (over a 64dBwhite noise background) (adolescentn15 control,n10 cKO;
adult n 9 control, n 9 cKO). ANOVA with repeated measure revealed significant main
effects of test-phase (4–12 dB) (F(2,42) 34.17, p 0.001 for adolescent mice; F(2,32)
81.33, p 0.001 for adults) and genotype (F(1,21) 11.95, p 0.01 for adolescent mice;
F(1,16) 31.67, p 0.001 for adults), but no test-phase genotype interactions. Bonferroni-
corrected pairwise comparisons noted that the PPI of mutants against all three prepulse levels
(4, 8, and 12 dB) were decreased in both adolescent and adult mice compared with their litter-
mate controls (*p 0.05). C, D, Preference ratio for nonsocial or social stimuli in the social
affiliation test (SAT) (adolescentn13control,n13cKO; adultn13control,n12cKO).
C, For adolescent mice, ANOVA with repeated measure revealed a significant main effects of
test-phase (F(1,23) 48.71, p 0.001). However, there was no genotype effect (F(1,23)
0.632, p  0.43), nor test-phase  genotype interaction. D, For adult mice, ANOVA with
repeated measure noted significant main effects of test-phase (F(1,20) 6.54, p 0.05) and
genotype effect (F(1,20) 14.38, p 0.001), whereas no significant test-phase genotype
interaction was detected. Bonferroni comparisons showed that the social interactions of adult
mutants with the stimulus mouse was decreased compared with littermate controls
(*p 0.001). E, F, Y-maze test ofworkingmemory showing the average of percentage correct
alternations. Dotted line indicates percentage alternations expected by chance (33%) (adoles-
cent n 14 control, n 13 cKO; adult n 9 control, n 9 cKO). Independent t test revealed
that the correct alteration rate of adolescent mutant mice was not different from littermate
controls (E) (t(1,25) 1.39, p 0.177), whereas adult mutants showed a significantly de-
creased correct alteration rate comparedwith their controls (F) (t(1,16) 2.52, p 0.05).G,H,
Novel object recognition (NOR) test of short-term(STM), long-term(LTM), and remotememory.
The preference score for the novel object is shown (adolescent n 14 control, n 13 cKO;
adult n 9 control, n 9 cKO). ANOVA with repeated measure revealed significant main
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effects of test-phase (F(3,75) 5.59, p 0.01 for adolescentmice; F(3,42) 3.53, p 0.05 for
adults), genotype (F(1,25)64.91,p0.001 for adolescentmice; F(1,14)23.59,p0.01 for
adults), and significant test-phase genotype interaction effect (F(3,75) 19.15, p 0.001
for adolescent mice; F(3,42) 7.14, p 0.001 for adults). Bonferroni-corrected pairwise com-
parisons noted that adolescent cKO mice have deficits in all three types of memory capability
(short-, long-term, and remote memory) compared with those of littermate controls
(*p 0.05).
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Genomic studies of risk factors has led to a developing consensus
that these disordersmay reflect a signaling network or “pathway”
dysfunction (Walsh et al., 2008; International Schizophrenia
Consortium et al., 2009; Gilman et al., 2011; Sakai et al., 2011;
Voineagu et al., 2011; Casey et al., 2012; Durand et al., 2012;
Leblond et al., 2012; Sullivan, 2012); one candidate pathway is the
regulation of the synaptic cytoskeleton. The Arp2/3 complex
plays a central role in controlling actin polymerization, position-
ing it as a hub downstream of multiple genes implicated in psy-
chiatric disorders (Kaufmann andMoser, 2000; Ramakers, 2002;
Hayashi-Takagi et al., 2010; Ito et al., 2010; Durand et al., 2012).
Upon deletion of ArpC3 (a subunit of the Arp2/3 complex),
the first phenotype to emerge was failure tomaintain the equilib-
rium of structural plasticity associated with LTP and LTD. Sub-
sequently, changes in spinemorphology became evident, with the
loss of large mushroom-shaped spines and an increase in
filopodial-like spines. This asymmetry of spine structural plastic-
ity may lead over time to an accumulation of unstable filopodial
spines that could lead to reduced spine density in vivo (Grutzendler
et al., 2002; Trachtenberg et al., 2002). Thus, Arp2/3 may be cru-
cial for experience-dependent plasticity and long-term stabiliza-
tion of spines in vivo. The loss of ArpC3 may also have other
consequences, including an impairment in activity-dependent
spinogenesis that also contributes to spine density in the postna-
tal period (Kwon and Sabatini, 2011). Importantly, abnormali-
ties in spine morphology have been described in multiple genetic
animal models of neuropsychiatric disorders, including SZ, ID,
and ASD (Comery et al., 1997; Govek et al., 2004; Barros et al.,
2009; Hayashi-Takagi et al., 2010; Ito et al., 2010; Carlson et al.,
2011; Durand et al., 2012) and in postmortem analysis of patients
with these disorders (Rudelli et al., 1985; Glantz and Lewis, 2000;
Ramakers, 2002; Kolomeets et al., 2005;Hutsler andZhang, 2010;
Penzes et al., 2011), implying a close relationship between spine
abnormalities and the pathology of neuropsychiatric disorders.
Corresponding to the time course of the evolving synaptic
dysfunctions, ArpC3f/f:CamKll-Cre mice progressively develop
multiple behavioral abnormalities. The sequence of this progres-
sion suggests that PPI and episodic memory may be more sensi-
tive to disturbances in plasticity, mimicking a prodromal state,
whilemarked disruptions inmotor responses and social behavior
may be secondary to spine loss. Genes involved in actin signaling
have been associated with multiple neuropsychiatric disorders;
which of these might the CamKll-Cre driven loss of Arp2/3 best
model?Overlap between signaling pathways and the synaptic and
behavior phenotypes of SZ, ID, and ASD complicates the inter-
pretation of genetic models of these disorders in experimental
animals.No single behavioral abnormality observed in theArpC3
cKO mice is specific for a single disorder, but the sum of the
abnormalities best corresponds to other models of SZ-related
disorders, since the mice progressively lose spine synapses and
over time exhibit reduced PPI, cognitive deficits, hyperactivity,
and social isolation.
SZ is distinguished from ID and ASD by several striking fea-
tures. SZ symptoms have a delayed onset, typically appearing in
adolescence or early adulthood (DeLisi, 1992; Insel, 2010).While
the basis for this delay is unknown, accumulating evidence indi-
cates that SZ evolves in distinct phases, with cognitive and some
negative symptoms arising first, followed by the onset of psycho-
sis (Tandon et al., 2009). Finally, the severity of symptoms may
increase gradually over time. The basis for these changes may be
related to structural alterations, as longitudinal studies report a
progressive loss of gray matter in SZ brains (Bennett, 2011), cor-
responding with a gradual loss of dendritic spines (Glantz and
Lewis, 2000).
Several lines of evidence support a role for dysregulation of
pathways governing spine actin remodeling in SZ. DISC1, a sus-
ceptibility gene for SZ, has been shown to regulate Rac signaling
to spine actin via the guanine nucleotide exchange factor
Kalirin-7, whose deletion in mice results in a progressive loss of
spines and several SZ-related behavioral abnormalities (Cahill et
al., 2009). Postmortem analysis reveals decreased expression of
proteins that regulate synaptic actin signaling, including Rho-
family GTPases (Hill et al., 2006). Another SZ-linked gene, DT-
NBP1, encodes the protein disbindin-1, which assembles in a
protein complex with Abi1 and WAVE family members impli-
cated in the maintenance of normal spine morphology (Ito et al.,
2010). Copy number variants associated with SZ also impact key
cytoskeletal signaling molecules, including CYFIP1 and WRP/
srGAP3, which regulate Rac-to-WAVE signal transduction
(Soderling et al., 2002; Stefansson et al., 2008; Addington and
Rapoport, 2009; Zhao et al., 2012). Possible risk-associated loci
for SZ also include genes encoding the Arp2/3 complex (Lips et
al., 2011). Reductions in the levels of NMDA receptor subunits
and PSD-95 similar to those we observe in theArpC3f/f:CamKll-
Cre mice have been reported also in individuals with SZ (Toro
and Deakin, 2005; Kristiansen et al., 2006), consistent with the
glutamate hypofunction theory of SZ (Javitt, 2004).
In summary, the cellular, biochemical, and behavioral results
presented here support the possibility that abnormal signaling to
the actin cytoskeleton via Arp2/3 is a common pathway that may
underlie multiple classes of psychiatric symptoms. Intriguingly,
the disruption of Arp2/3 in the forebrain can recapitulate the
functional manifestations of many upstream candidate genes
Figure 8. Schematic model summarizing the progressive development of synaptic and be-
havioral abnormalities following ArpC3 deletion. Loss of ArpC3 in postnatal excitatory neurons
of forebrain results in twophasesof progressive synaptic abnormalities; anearly impairments of
actin turnover and structural plasticity of spines (purple line), followed by a second phase
of gradual loss of spine synapses (red line). Each phase is associated with a distinct progression
of multiple behaviors related to psychiatric disorders (blue line). Dotted line indicates normal
range.
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previously associated with SZ. Disruption of Arp2/3 in other cir-
cuits and neuronal cell types may be an effective approach to
model disorders of the CNS thought to arise from altered actin
signaling pathways.
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